Model Number 3CX*FX25RWC |
Device Problem
Leak/Splash (1354)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Type
Injury
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the advance capiox fx25 leaks blood in an exit to the manifold.Per subsidiary the customer sealed the leak by using a medical tape.The product was disposed and not available for return.Transfusion of one unit of erg.Product was not changed out.Procedure was completed successfully with delay.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on october 12, 2021.Upon further investigation of the reported event, the following information is new and/or changed: a2 (added age).A3 (added gender).B1 (added report type).B2 (added outcomes attributed to adverse event).B5 (describe event or problem - added new information).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H6 - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Event Description
|
Received new information, no delay in the procedure and there was a blood loss of 500 ml of blood.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: g6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H6 (identification of evaluation codes 11, 3331, 4114, 4210, 4307).Type of investigation #1: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #2: 3331 - analysis of production records.Type of investigation #3: 4114 - device not returned.Investigation findings: 4210 - leakage/seal.Investigation conclusions: 4307 - cause traced to component failure.The affected sample was not returned so a thorough investigation could not be conducted.However, pictures provided confirmed the event.A representative retention sample was inspected to confirm no visual damage or anomalies with the arterial pigtail.All capiox units are 100% visually inspected at several points in the production process.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|